All articles by Aninda Chakraborty

  1. Innovation Pharmaceuticals doses first cohort in oral brilacidin trial

    Innovation Pharmaceuticals has completed dosing of the first cohort of subjects in its Phase I trial of oral brilacidin. The…
    Read More…

    17 Jan
  2. Neuroptika enrols first patient for dry eye disease trial

    Neuroptika has enrolled the first patient in a Phase II clinical trial of NRO-1 for the treatment of dry eye…
    Read More…

    17 Jan
  3. BioTheryX initiates patient dosing in trial of BTX-A51 for AML

    BioTheryX has initiated patient dosing in a Phase I study of BTX-A51 for the treatment of relapsed/refractory acute myeloid leukaemia…
    Read More…

    17 Jan
  4. BerGenBio reports positive results from first stage of NSCLC study

    Norwegian biopharmaceutical company BerGenBio has reported positive results from the first stage of a Phase II trial (BGBC008) assessing the…
    Read More…

    16 Jan
  5. Euan MacDonald Centre launches motor neurone disease trials in UK

    The Euan MacDonald Centre at the University of Edinburgh has launched a clinical drug trial for Motor Neurone Disease (MND)….
    Read More…

    16 Jan
  6. Tolero Pharmaceuticals doses first patient in Phase II Zella 202 study

    Tolero Pharmaceuticals has dosed the first patient in a Phase II Zella 202 study of investigational agent alvocidib. The study…
    Read More…

    16 Jan
  7. Verona Pharma reports positive top-line data from COPD trial

    Verona Pharma has reported positive top-line data from a Phase IIb dose-ranging study assessing the efficacy of ensifentrine for the…
    Read More…

    14 Jan
  8. Terns Pharmaceuticals reports positive results from TERN-201 trial

    Terns Pharmaceuticals has reported positive results from an ongoing Phase I clinical trial of TERN-201 for the treatment of non-alcoholic…
    Read More…

    13 Jan
  9. Nektar and Bristol-Myers Squibb expand clinical development programme

    Nektar Therapeutics and Bristol-Myers Squibb Company have entered a revised strategic collaboration agreement to expand the clinical development programme for…
    Read More…

    13 Jan
  10. Zymeworks begins trial to test ZW25 as a combination therapy

    Zymeworks has initiated a Phase II trial to assess the efficacy of ZW25 as a combination therapy for previously-treated locally…
    Read More…

    13 Jan
Close
Close
Close

Go Top